Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bolt Biotherapeutics (BOLT) Equity Ratio (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Equity Ratio for 6 consecutive years, with 0.47 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 18.64% to 0.47 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.47 through Dec 2025, down 18.64% year-over-year, with the annual reading at 0.47 for FY2025, 18.64% down from the prior year.
  • Equity Ratio hit 0.47 in Q4 2025 for Bolt Biotherapeutics, down from 0.49 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.93 in Q1 2021 to a low of 0.47 in Q4 2025.
  • Historically, Equity Ratio has averaged 0.71 across 5 years, with a median of 0.74 in 2023.
  • Biggest five-year swings in Equity Ratio: surged 136.05% in 2021 and later fell 25.59% in 2025.
  • Year by year, Equity Ratio stood at 0.81 in 2021, then dropped by 7.38% to 0.75 in 2022, then dropped by 6.28% to 0.71 in 2023, then decreased by 18.64% to 0.57 in 2024, then fell by 18.64% to 0.47 in 2025.
  • Business Quant data shows Equity Ratio for BOLT at 0.47 in Q4 2025, 0.49 in Q3 2025, and 0.51 in Q2 2025.